title: The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote.
abstract: BACKGROUND
  Inheritance of the F variant of alpha-1-antitrypsin is associated with normal circulating protein levels, but it is believed to be dysfunctional in its ability to inhibit neutrophil elastase and therefore has been implicated as a susceptibility factor for the development of emphysema. In this study, its functional characteristics were determined following the identification of a unique patient with the PiFF phenotype, and the implications as a susceptibility factor for emphysema are considered both in homozygotes and heterozygotes.
  
  
  METHODS
  Second order association rate constants were measured for M, Z, S and F variants of alpha-1-antitrypsin with neutrophil elastase and proteinase 3. Clinical characteristics of the PiFF homozygote and six PiFZ heterozygote subjects were studied.
  
  
  RESULTS
  The F variant had a reduced association rate constant with neutrophil elastase (5.60 ± 0.83 × 106 M-1 s-1) compared to the normal M variant (1.45 ± 0.02 × 107 M-1 s-1), indicating an increased time to inhibition that was comparable to that of the Z variant (7.34 ± 0.03 × 106 M-1 s-1). The association rate constant for the F variant and proteinase 3 (1.06 ± 0.22 × 106 M-1 s-1) was reduced compared to that with neutrophil elastase, but was similar to that of other alpha-1-antitrypsin variants. Of the six PiFZ heterozygotes, five had airflow obstruction and radiological evidence of emphysema. The PiFF homozygote had airflow obstruction but no emphysema. None of the patients had clinical evidence of liver disease.
  
  
  CONCLUSIONS
  The F variant may increase susceptibility to elastase-induced lung damage but not emphysema, whereas co-inheritance with the Z deficiency allele may predispose to emphysema despite reasonable plasma concentrations of alpha-1-antitrypsin.
authors.forename: Nicola Jane
authors.initials: NJ
authors.lastname: Sinden
authors.forename: Firas
authors.initials: F
authors.lastname: Koura
authors.affiliation: Centre for Translational Inflammation Research, University of Birmingham, Birmingham, UK. rob.stockley@uhb.nhs.uk.
authors.forename: Robert Andrew
authors.initials: RA
authors.lastname: Stockley
mesh_terms: D000368:Aged; D004646:Emphysema / Q000201:enzymology / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007700:Kinetics; D019272:Leukocyte Elastase / Q000037:antagonists & inhibitors*; D008297:Male; D053146:Myeloblastin / Q000037:antagonists & inhibitors; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D000515:alpha 1-Antitrypsin / Q000235:genetics / Q000378:metabolism*; D019896:alpha 1-Antitrypsin Deficiency / Q000150:complications / Q000235:genetics / Q000378:metabolism*
chemical_list: D000515:alpha 1-Antitrypsin; D019272:Leukocyte Elastase; D053146:Myeloblastin
references.citation: Science. 1965 Aug 27;149(3687):986-7
references.pmid: 5827347
references.citation: Thorax. 2004 Oct;59(10):843-9
references.pmid: 15454649
references.citation: Hum Genet. 1982;61(2):118-22
references.pmid: 6182087
references.citation: J Biol Chem. 1979 May 25;254(10):4027-32
references.pmid: 312290
references.citation: Thorax. 1989 Sep;44(9):758-9
references.pmid: 2588214
references.citation: Am J Respir Crit Care Med. 2000 Jan;161(1):81-4
references.pmid: 10619801
references.citation: N Engl J Med. 1986 Mar 20;314(12):736-9
references.pmid: 3485248
references.citation: J Clin Pathol. 1976 Jan;29(1):63-8
references.pmid: 55420
references.citation: J Clin Invest. 1987 Nov;80(5):1366-74
references.pmid: 3500183
references.citation: Clin Genet. 1984 Jun;25(6):491-5
references.pmid: 6610506
references.citation: Chest. 2009 Nov;136(5):1284-1290
references.pmid: 19892672
references.citation: Gastroenterology. 1974 Feb;66(2):264-8
references.pmid: 4359391
references.citation: Nat Protoc. 2008;3(6):991-1000
references.pmid: 18536646
references.citation: Allergy Asthma Clin Immunol. 2011 Nov 13;7(1):18
references.pmid: 22078084
references.citation: Pathology. 1996 Aug;28(3):242-7
references.pmid: 8912354
references.citation: Am J Respir Crit Care Med. 2014 Feb 15;189(4):419-27
references.pmid: 24428606
references.citation: Chest. 1991 Sep;100(3):703-8
references.pmid: 1889260
references.citation: J Clin Invest. 1999 Apr;103(7):999-1006
references.pmid: 10194472
references.citation: Acta Med Scand. 1964 Feb;175:197-205
references.pmid: 14124635
references.citation: Eur Respir J. 2013 May;41(5):1042-50
references.pmid: 22936713
references.citation: Am J Hum Genet. 1991 Jun;48(6):1154-8
references.pmid: 2035534
references.citation: Am J Respir Cell Mol Biol. 2005 Jun;32(6):553-9
references.pmid: 15764720
references.citation: J Mol Biol. 2001 Feb 9;306(1):109-19
references.pmid: 11178897
references.citation: Chest. 2010 Nov;138(5):1125-32
references.pmid: 20595457
references.citation: J Clin Invest. 1999 Aug;104(3):337-44
references.pmid: 10430615
references.citation: J Clin Invest. 2002 Dec;110(11):1585-90
references.pmid: 12464660
references.citation: Can Med Assoc J. 1981 Mar 15;124(6):737-42
references.pmid: 6970613